Figure 7: Kaplan-Meier plot of pancreatic cancer patient survival based on the existence of MEF2A-105-Y-C-Phosphorylation. | Scientific Reports

Figure 7: Kaplan-Meier plot of pancreatic cancer patient survival based on the existence of MEF2A-105-Y-C-Phosphorylation.

From: Distribution bias analysis of germline and somatic single-nucleotide variations that impact protein functional site and neighboring amino acids

Figure 7

X-axis indicate days of survival and Y-axis indicates survival probability. Red and blue lines indicate survival time of pancreatic cancer patients with and without such mutation respectively. Log-rank test shows that, comparing with patients with MEF2A-105-Y-C-Phosphorylation, patients without this pfsSNV survive significantly longer with adjusted p-value of 0.0255. The hazard ratio is 2.348.

Back to article page